This study was conducted to assess the effect of exposure misclassification when coffee is used as a surrogate measure of caffeine exposure. Subjects were randomly selected from the telephone directories of four regional municipalities in southern Ontario, Canada. Data on daily caffeine intake from foods, beverages, and medications were collected from June to November 1995 through self-administered, mailed questionnaires from 481 men and women aged 30-75 years. Although coffee was the main source of caffeine, cross-tabulations of exposure to coffee by total caffeine intake showed that assessment of coffee alone severely underestimated caffeine intake by at least one exposure level. A hypothetical 10-fold increase in risk was completely obscured when only coffee was used to estimate total caffeine intake. The results of this study suggest that measuring coffee instead of caffeine intake may contribute to a lack of positive findings in studies of coffee as a risk factor for disease occurrence, if in fact caffeine is the exposure of interest. On the other hand, measurement of coffee, tea, and cola soft drink intake in the present study appeared to approximate caffeine intake sufficiently and not affect risk estimates adversely. Am J Epidemiol 2001;153:815-20. 
Despite extensive examination in epidemiologic studies, neither coffee nor caffeine consumption has been associated consistently with disease occurrence. In some areas of research, coffee is the focus of interest (e.g., pancreatic cancer (1) (2) (3) (4) (5) (6) (7) (8) , coronary heart disease (9-12)); in other research, caffeine has been studied more intensively (e.g., breast disease (13) (14) (15) (16) (17) , reproductive issues (18) (19) (20) (21) (22) ). The literature suggests that although coffee contains many different chemical compounds, no certainty exists as to which ones may be associated with disease risk. Caffeine, the main psychoactive ingredient in coffee, has been the substance studied most often. Because the underlying biologic pathways that might involve coffee and/or caffeine in causing disease are largely unknown, it is difficult to determine the exposure of interest. Perhaps the lack of certainty about which exposure should be measured, combined with the fact that coffee is the main source of caffeine, has led to a tendency to equate the two exposures.
The confusion in distinguishing between the effects of coffee and caffeine is reflected in literature reviews that often report results from coffee and caffeine studies together (20, 23, 24) . Review articles on the health effects of caffeine and caffeine-related compounds either use evidence or draw conclusions from studies that measured coffee consumption alone (8, 13, (25) (26) (27) . This lack of distinction has resulted in incomplete caffeine measurement; that is, only coffee intake is examined and other significant sources of caffeine are not included (13, 23, 28, 29) . To our knowledge, only one study (30) to date has examined this type of misclassification of exposures, and no study has yet examined the effects this misclassification might have on effect estimates.
The objectives of this study were to assess the extent of underestimation when coffee is used as a surrogate for total caffeine intake and the effects on odds ratio estimation for multiple levels of exposure.
MATERIALS AND METHODS
Study subjects were randomly selected from the telephone directories of four regional municipalities in southern Ontario, Canada: Halton-Peel, Hamilton-Wentworth, Durham, and York. Eligible subjects were men and women aged 30-75 years residing in Ontario. The sample was stratified by sex and age (i.e., 30-44, 45-59, and 60-75 years) because of evidence that caffeine consumption patterns vary by age and sex (30-32; M. Agha, Institute for Clinical Evaluative Sciences, personal communication, May 14, 1996) . Subjects were recruited from June to November 1995.
People were initially contacted by telephone to determine whether they would participate in this study by completing a mailed questionnaire. During this call, they were asked to provide their age to ensure that they were eligible for the study. Of the 2,761 telephone numbers called, 331 numbers were nonresidential; 856 respondents were ineligible according to the age criterion or to age-sex-filled quotas; and, for 331 numbers, there was no answer or no one who understood English. Thus, 1,243 respondents remained, and 591 (47.5 percent) agreed to participate. Of the 591 people who consented, 487 (82.4 percent) returned the completed questionnaire. Six questionnaires were excluded from the analysis: three people were not living in Ontario and three were ineligible because of their age. Thus, 481 questionnaires were retained for analysis.
The questionnaire elicited demographic and anthropometric data, a selected medical history, exposure to tobacco, reproductive history (women only), and a brief dietary history. It was designed to collect complete information on caffeine intake from foods, beverages, and medications. Subjects were asked to report when they began consuming a caffeine-containing substance, the usual number of servings or dose per day, and, if applicable, when they stopped doing so. Serving size was not specified on the questionnaire. Daily caffeine intake was calculated by including only current intake of the different caffeine sources; lifetime measures (not reported in this paper) added the dimension of length of intake to each caffeine source.
Total caffeine intake was categorized by using the same caffeine cutpoints as those for coffee. Telephone calls were made to respondents for clarification or to obtain additional information if any caffeine data were missing.
Total daily intake of caffeine was calculated by multiplying servings/dose of each caffeine source by its median caffeine content and then summing for all sources. The caffeine levels (mg/standard unit) used to calculate intake from foods and beverages were as follows: regular coffee (i.e., brewed or percolated), 115 mg; instant coffee, 70 mg; decaffeinated coffee, 3 mg; espresso, 100 mg; cappuccino, 100 mg; regular tea, 50 mg; chocolate drinks, 6 mg; chocolate bars, 6 mg; and cola soft drinks, 50 mg (13, 23, 28, 32, 33) . Information was collected on 23 caffeine-containing medications, including analgesic, diet, migraine, and menstrual. The pertablet caffeine content of these medications ranges from 15 to 100 mg (34, 35) . Estimates of consumption of each measure were calculated for each of the six age-sex-specific strata and for all strata combined.
Caffeine intake (mg) from regular coffee was classified into approximate quartiles. Total caffeine intake was then categorized by using the same cutpoints, and cross-tabulations were constructed. Calculations were performed on estimates of daily intake within age and sex strata and for all strata combined.
The cross-tabulations, which led to misclassification estimates, provided the basis for studying the effects of underestimating risk when regular coffee is used to approximate total caffeine intake. A hypothetical case-control distribution was constructed to provide various odds ratio estimates reflecting both threshold and dose-response associations between total caffeine intake and disease occurrence. The distribution of "controls" reflected the caffeine intake reported by our study sample, while the number of "cases" was back-calculated to yield the desired odds ratios. Subjects were then reclassified into the caffeine exposure level based on caffeine estimates from coffee only, assuming nondifferential misclassification for cases and controls (36) . These "misclassified" odds ratio estimates (coffee alone) were compared with the "true" odds ratio estimates (all sources of caffeine). Once again, calculations were performed for all age-sex strata separately, in which misclassification estimates for each stratum were used, and then for the combined sample.
RESULTS
In all strata, the four main sources of caffeine were regular coffee, instant coffee, regular tea, and cola soft drinks (tables 1 and 2). These sources accounted for 90-98 percent of total daily caffeine intake. Males (table 1) had a higher caffeine intake than females (table 2) , and respondents aged 45-59 years had a higher caffeine intake than the other two age groups.
Regular coffee was the main source of caffeine (42-63 percent) for all age-sex strata. Females were less likely to report drinking coffee, and female coffee drinkers reported fewer daily servings than did their males counterparts (data not shown).
Tea and cola soft drinks ranked second or third as a caffeine source, depending on the age-sex stratum. Cola soft drinks tended to be the preferred drink for the youngest age group and tea for the oldest. Cola soft drinks were more popular among males, whereas tea was more popular among females. Tea intake was high enough among females aged 60-75 years to nearly equal their daily caffeine intake from coffee. Table 3 shows the underestimation that would occur for various exposure levels if coffee alone were used to estimate caffeine intake. For example, of the 65 persons whose total daily caffeine exposure was equivalent to 1-115 mg, 94 percent would have been classified as nonexposed on the basis of their regular coffee intake. Of the 93 persons whose total daily caffeine exposure was 116-230 mg, 2 percent would have been classified correctly on the basis of their regular coffee intake, a further 48 percent would have been classified incorrectly in the next-lowest exposure group (1-115 mg), and 49 percent would have been classified incorrectly as nonexposed.
The effects of exposure misclassification on odds ratios estimation are shown in table 4. When we set the true odds ratios to 2.0 for all exposure levels of daily intake and used the nonexposed group as the referent, the resulting misclassified odds ratio estimates were 1.0 for the total sample at all levels of exposure and ranged from 1.0 to 1.1 by age-sex stratum. When the hypothetical odds ratios were increased to 10.0, the misclassified odds ratio estimates for the overall sample were 1.0 for all levels of exposure. For this scenario, the misclassified odds ratio estimates according to age and sex also ranged from 1.0 to 1.1. These results indicate that a 10-fold increase in risk for exposure to caffeine would be obscured completely if only regular coffee intake was measured. When we applied a dose-response relation to the hypothetical odds ratios, the resulting misclassified odds ratio estimates showed a much-diluted dose-response relation. At the two intermediate levels of exposure, the odds ratio estimates were diluted to approximately 1.0 and in some cases were slightly below 1.0. At the highest level of exposure, the misclassified odds ratio was diluted from 3.0 to 1.2. All age-sex strata were affected similarly. Table 5 presents some sample data showing the corrections made to a true dose-response relation. For these corrected estimates, we used information from the cross-tabulation values (table 3) and formulae derived from Kleinbaum et al. (36) (available from the authors on request). Although the numbers were small, "no exposure" was chosen as the referent category, as this definition is the one most commonly used in the literature and represents the most appropriate baseline in the absence of any concrete knowledge about the effects of caffeine. An analysis in which the referent category was defined as less than 50 mg resulted in odds ratio estimates within 0.1 of those from the analyses presented here. When 21 (53) 15 (32) 29 (51) 46 (48) 6 (30) 3 ( 45 (81) 10 (32) 53 (73) 53 (64) 5 (21) 1 ( * SD, standard deviation. † The sum of caffeine intake from the following sources: decaffeinated coffee (3 mg/serving), cappuccino (100 mg/serving), and espresso (100 mg/serving). 24 (49) 11 (28) 68 (86) 39 (48) 5 (22) 2 ( 25 (59) 18 (45) 74 (77) 32 (42) 13 (43) 1 ( * SD, standard deviation. † The sum of caffeine intake from the following sources: decaffeinated coffee (3 mg/serving), cappuccino (100 mg/serving), and espresso (100 mg/serving). % caffeine 131 (151) 45 (91) 4 (6) 106 (220) 16 (32) 10 (48) 2 ( the referent category was defined as less than 115 mg of caffeine, the misclassified odds ratio estimate was still substantially attenuated. It did not exceed 1.7 even with a true odds ratio of 10.0.
Since many studies have assumed that regular rather than instant coffee was the type consumed, reported regular coffee intake was used as the surrogate measure. However, true odds ratio estimates were also "corrected" by combining all types of coffee; these estimates did not differ by more than 0.1 from the "corrections" based on intake of caffeine from regular coffee alone (data not shown). Thus, the biases from using caffeine intake from all types of coffee combined and from regular coffee only as a surrogate measure for caffeine are similar.
Lifetime measures of caffeine intake are not highlighted in this paper because the effect of misclassification was similar to that of daily intake. Since the questionnaire did not account for multiple changes in level of intake throughout life, lack of precision may have contributed to the similarity of results.
Odds ratio estimates were also calculated for lifetime measures of caffeine intake. Misclassified lifetime odds ratio estimates did not differ by more than 0.2 from the misclassified daily odds ratio estimates (data not shown). When odds ratio estimates of caffeine intake from all types of coffee, regular tea, and cola soft drinks were compared with odds ratio estimates based on total caffeine intake from all sources, the former were not misclassified by more than 0.1 (data not shown).
DISCUSSION
Our findings demonstrate that measuring coffee instead of caffeine intake may contribute to the lack of positive find- ings in studies of coffee as a risk factor for various diseases, if in fact caffeine is the exposure of interest. Although the tendency has been to equate coffee and caffeine exposure (13, 20, 23, 24, 27, 29) , our results highlight the necessity of separating them. Despite coffee being the major source of caffeine intake, a significant underestimation occurs when coffee is used as a surrogate measure for caffeine intake. The difference between resulting odds ratio estimates, depending on which exposure is used, suggests that this underestimation masks even extreme associations not typically found in epidemiologic studies. The extent of misclassification was not substantially altered by our choice of referent group, inclusion of all types of coffee, or use of lifetime consumption measures.
A number of problems arise in estimating coffee and caffeine intake. Accurate recall is a potential problem in all dietary studies, although there is some suggestion that reported coffee consumption is less variable than reported food consumption from day to day (37) . Furthermore, lack of precision in measuring caffeine intake has been established as a significant source of error in caffeine-related research (30) (31) (32) 38) . The reliability of such estimates has been brought into question because of the many factors (e.g., brand name, strength of brew, type of coffee bean, brewing method, and volume) affecting the amount of caffeine in foods and beverages. There is also a large fluctuation in how the same person prepares coffee and tea (28) . For these reasons, it is extremely difficult to develop a single value of caffeine for any food or beverage. While our data may have suffered from imprecision in measuring exact content (mg), we obtained estimates by using methods similar to those in other studies. Thus, the underestimates should be comparable to those found in other studies.
Although few persons in our sample reported intermittent coffee drinking, it may be useful in future studies to collect more detailed information on occasional consumption to improve the precision of caffeine estimates. Another element that might affect estimates of caffeine consumption is increasing intake of decaffeinated cola soft drinks. The beverage industry reported that in 1994, approximately 5 percent of all cola soft drinks sold were decaffeinated (32) . Similarly, decaffeinated specialty coffees may also be increasing in popularity.
Of some concern is that our sample reported lower coffee consumption than has been reported in previous studies (1-7) and therefore might not yield the same misclassification estimates. However, since coffee consumption patterns in our sample were similar to those in the Ontario Health Survey (M. Agha, Institute for Clinical Evaluative Sciences, personal communication, May 14, 1996) , and the extent of underestimation was similar to that reported by Schreiber et al. (30) , it seems reasonable to assume that our sample illustrates the potential effects of underestimation on odds ratio estimation. While consumption patterns might vary in different populations, as long as total caffeine consumption does not derive solely from coffee, misclassification will be present. Our results suggest that in future studies that estimate caffeine intake, data should be collected on the main sources of caffeine and not on coffee alone. Odds ratio * Values based on formulae extended from Kleinbaum et al. (36) .
† Values based on the exposure distribution reported in the entire study sample.
‡ Numbers do not total 1,000 because of rounding. § 0 cups = 0 mg, ≤1 cup = 115 mg, 2 cups = 116-230 mg, >2 cups = ≥231 mg. Misclassified population using caffeine estimates from regular coffee
